The Fight Against COVID19
23.81k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
TREA analyzes over 100 million data points, interactions, relationships on company research and development activities, allowing investors to quickly gain insight without having to go through complex regulatory filings. Primary data sources include: FDA (Food and Drug Administration), NIH (National Institutes of Health), USPTO (US Patent and Trademark Office). The search parameters for generating this watchlist were (1) Above sector average Innovation Index score, (2) IP history at least 5 years (3) COVID19 (4) 2019-nCov (5) SARS-CoV-2 among others.
Performance
| Watchlist | Change Today | 1 Month Return | 1 Year Return | Total Return |
|---|---|---|---|---|
| The Fight Against COVID19 | - | - | - | - |
| ^GSPC | +1.26% | -1.47% | +23.97% | +5413.75% |
14 Symbols
| Symbol | Company Name | Last Price | Change | % Change | Market Time | Volume | Avg Vol (3 month) | Market Cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 149.27 | -0.65 | -0.43% | 4:00 p.m. EDT | 6.46M | 7.76M | 359.25B |
| ABBV | AbbVie Inc. | 163.79 | +2.98 | +1.85% | 4:00 p.m. EDT | 3.98M | 5.74M | 290.01B |
| PFE | Pfizer Inc. | 27.81 | +0.11 | +0.40% | 4:00 p.m. EDT | 28.21M | 41.44M | 157.48B |
| SNY | Sanofi | 49.01 | -0.45 | -0.91% | 4:00 p.m. EDT | 1.11M | 2.12M | 122.94B |
| REGN | Regeneron Pharmaceuticals, Inc. | 957 | +19.39 | +2.07% | 4:00 p.m. EDT | 525.99k | 472.84k | 105.45B |
| GSK | GSK plc | 43.5 | +0.15 | +0.35% | 4:00 p.m. EDT | 3.37M | 3.49M | 88.70B |
| GILD | Gilead Sciences, Inc. | 64.78 | -0.55 | -0.84% | 4:00 p.m. EDT | 7.75M | 7.40M | 80.78B |
| MRNA | Moderna, Inc. | 125 | -0.59 | -0.47% | 4:00 p.m. EDT | 4.47M | 3.92M | 47.91B |
| TAK | Takeda Pharmaceutical Company Limited | 13.37 | +0.10 | +0.75% | 4:00 p.m. EDT | 1.33M | 1.69M | 42.28B |
| BNTX | BioNTech SE | 92.72 | +0.48 | +0.52% | 4:00 p.m. EDT | 659.87k | 587.56k | 22.34B |
| VIR | Vir Biotechnology, Inc. | 10.39 | +1.21 | +13.18% | 4:00 p.m. EDT | 1.66M | 1.04M | 1.41B |
| NVAX | Novavax, Inc. | 4.93 | +0.22 | +4.67% | 4:00 p.m. EDT | 4.60M | 6.98M | 692.19M |
| INO | Inovio Pharmaceuticals, Inc. | 12.1 | +0.09 | +0.75% | 4:00 p.m. EDT | 295.50k | 464.85k | 313.47M |
Yahoo FinanceAmgen's peek at its GLP-1 drug trial results heightens competition in obesity market
Competition is heating up in the GLP-1 space as Amgen gets closer to the finish line with its candidate.
Simply Wall St.Do These 3 Checks Before Buying Pfizer Inc. (NYSE:PFE) For Its Upcoming Dividend
Readers hoping to buy Pfizer Inc. ( NYSE:PFE ) for its dividend will need to make their move shortly, as the stock is...
Simply Wall St.Analysts Are Updating Their Moderna, Inc. (NASDAQ:MRNA) Estimates After Its First-Quarter Results
Moderna, Inc. ( NASDAQ:MRNA ) just released its quarterly report and things are looking bullish. Revenues of US$167m...
Sign in to view your followed lists
© 2024 Yahoo. All rights reserved.